Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002588344 | SCV003494476 | pathogenic | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2022-04-12 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 5 of the MTHFR gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MTHFR are known to be pathogenic (PMID: 25736335). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with methylene tetrahydrofolate reductase (MTHFR) deficiency (PMID: 25079578). This variant is also known as IVS5-1G>A. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003459753 | SCV004196393 | pathogenic | Neural tube defects, folate-sensitive | 2023-10-25 | criteria provided, single submitter | clinical testing |